Alnylam Pharmaceuticals
Develops RNAi therapeutics to treat rare and common diseases.
H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.
biotechpharmaceuticals
Company facts
- Founded
- 2002
- Employees
- 2,500
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: ALNY
Open positions
7 jobs
12 views 4 days ago
Senior Director, Global Pharmacovigilance Quality Assurance Lead
Open 32d HybridNorth AmericaFull-timeLead H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.
United States
Cambridge, MA, Philadelphia, PA, VirtualExecutive-level QA leadership role owning Alnylam's global pharmacovigilance quality system: setting GVP QA strategy, running risk-based audits, overseeing quality events/CAPAs and computerized-system compliance, and leading health-authority inspection readiness. Hybrid in Cambridge, MA or Philadelphia, PA, or remote within the US.
GCP Regulatory Compliance
228K – 308K $